Platelet-Inhibitor Drug Trial in Coronary Angioplasty

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 1983

Study Completion Date

September 30, 1988

Conditions

Angina PectorisCardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial Ischemia

Interventions

DRUG

aspirin

DRUG

dipyridamole

PROCEDURE

angioplasty, transluminal, percutaneous coronary

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000510 - Platelet-Inhibitor Drug Trial in Coronary Angioplasty | Biotech Hunter | Biotech Hunter